Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry:: Implications for dose specification and prescription

被引:49
作者
Williamson, JF
Coursey, BM
DeWerd, LA
Hanson, WF
Nath, R
Rivard, MJ
Ibbott, G
机构
[1] Washington Univ, Med Ctr, Radiat Oncol Ctr, St Louis, MO 63110 USA
[2] Natl Inst Stand & Technol, Ionizing Radiat Div, Gaithersburg, MD 20899 USA
[3] Univ Wisconsin, Accredited Dosimetry & Calibrat Lab, Madison, WI 53706 USA
[4] Univ Texas, MD Anderson Canc Ctr, Radiol Phys Ctr, Houston, TX 77030 USA
[5] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06510 USA
[6] Tufts Univ New England Med Ctr, Dept Radiat Oncol, Boston, MA 02111 USA
[7] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA
关键词
Pd-103; brachytherapy; air-kerma strength; dose prescriptions;
D O I
10.1118/1.598923
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The National Institute of Standards and Technology (NIST) introduced a national standard for air kerma strength of the ThreaSeed(R) Model 200 Pd-103 source (the only Pd-103 Seed available until 1999) in early 1999. Correct implementation of the NIST-99 standard requires the use of dose rate constants normalized to this same standard. Prior to the availability of this standard, the vendor's calibration procedure consisted of intercomparing Model 200 seeds with a Cd-109 source with a NIST-traceable activity calibration. The AAPM undertook a comprehensive review of Pd-103 source dosimetry including (i) comparison of the vendor and NIST-99 calibration standards; (ii) comparison of original Task Group 43 dosimetry parameters with more recent studies; (iii) evaluation of the vendor's calibration history; and (iv) evaluation of administered-to-prescribed dose ratios from the introduction of Pd-103 sources in 1987 to the present. This review indicates that for a prescribed dose of 115 Gy, the administered doses were (a) 124 Gy for the period 1988-1997 and (b) 135 Gy for the period 1997-1999. The AAPM recommends that the following three steps should be undertaken concurrently to implement correctly the 1999 dosimetry data and NIST-99 standard for Pd-103 source: (1) the vendor should provide calibrations in terms of air kerma strength traceable to NIST-99 standard, (2) the medical physicist should update the treatment planning system with properly normalized (to NIST-99) dosimetry parameters for the selected Pd-103 source model, and (3) the radiation oncologist in collaboration with the medical physicist should decide which clinical experience they wish to duplicate; the one prior to 1997 or the one from 1997 to 1999. If the intent is to duplicate the experience prior to 1997, which is backed by the long-term follow-up and published outcome studies, then the prior prescriptions of 115 Gy should be replaced by 124 Gy to duplicate that experience. (C) 2000 American Association of Physicists in Medicine.
引用
收藏
页码:634 / 642
页数:9
相关论文
共 24 条
[1]   A NOMOGRAPH FOR PERMANENT IMPLANTS OF PD-103 SEEDS [J].
ANDERSON, LL ;
MONI, JV ;
HARRISON, LB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (01) :129-135
[2]   Clinical impact of implementing the recommendations of AAPM task group 43 on permanent prostate brachytherapy using 125I [J].
Bice, WS ;
Prestidge, BR ;
Prete, JJ ;
Dubois, DF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (05) :1237-1241
[3]   THERMOLUMINESCENT DOSIMETRY FOR PD-103 SEEDS (MODEL 200) IN SOLID WATER PHANTOM [J].
CHIUTSAO, ST ;
ANDERSON, LL .
MEDICAL PHYSICS, 1991, 18 (03) :449-452
[4]  
CHU, WWW TABLE RADIOACTIV
[5]  
COURSEY BM, 1999, MODEL 200 AIR KERMA
[6]   Pd-103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma [J].
Dattoli, M ;
Wallner, K ;
Sorace, R ;
Koval, J ;
Cash, J ;
Acosta, R ;
Brown, C ;
Etheridge, J ;
Binder, M ;
Brunelle, R ;
Kirwan, N ;
Sanchez, S ;
Stein, D ;
Wasserman, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05) :875-879
[7]   Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43 [J].
Furhang, EE ;
Anderson, LL .
MEDICAL PHYSICS, 1999, 26 (02) :153-160
[8]  
JACOBS MC, 1997, COMMUNICATION 1015
[9]  
LI Z, 1999, RAD ONCOLOGY
[10]  
LOEVINGER R, 1993, MED PHYS, V20, P907